The usefulness of tumor necrosis factor-like weak inducer of apoptosis in patients with acute ST-elevation myocardial infarction
dc.authorid | CELIKKOL, ALIYE/0000-0002-3799-4470 | |
dc.authorid | Aydin, Cihan/0000-0002-1401-5727 | |
dc.contributor.author | Celikkol, A. | |
dc.contributor.author | Demirkiran, A. | |
dc.contributor.author | Aydin, C. | |
dc.date.accessioned | 2024-10-29T18:00:08Z | |
dc.date.available | 2024-10-29T18:00:08Z | |
dc.date.issued | 2023 | |
dc.department | Tekirdağ Namık Kemal Üniversitesi | |
dc.description.abstract | OBJECTIVE: We aimed to determine the utility of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) for the early diagnosis and prognosis of acute ST-elevation myocardial infarction (STEMI). PATIENTS AND METHODS: Patients presented with STEMI arrived at the hospital within 45 minutes after the onset of chest pain were included in this study. Blood samples for TWEAK, high-sensitivity C-reactive protein (hs-CRP), creatine kinase MB isoenzyme (CK-MB), and high-sensitivity cardiac troponin T (hs-TnT) levels were obtained at the time of arrival at the hospital. Subsequent samples were drawn at 4 h after primary percutaneous coronary intervention. RESULTS: The study cohort comprised patients with confirmed STEMI between January 2022 and September 2022, for a total of 45 enrolled STEMI patients. Plasma TWEAK levels were markedly elevated at hospital arrival, followed by a decrease at 4 hours after successful primary percutaneous coronary revascularization (PPCI). High-sensitive troponin T (HsTropT), CK-MB, and CRP were found within normal limits at the hospital arrival. Conversely, increased levels of CRP, CKMB, and hs-TropT were observed at 4 hours after PPCI. CONCLUSIONS: Plasma TWEAK levels were elevated earlier in the acute phase and decreased earlier after PPCI than other classic myocardial biomarkers. | |
dc.identifier.endpage | 7643 | |
dc.identifier.issn | 1128-3602 | |
dc.identifier.issue | 16 | en_US |
dc.identifier.pmid | 37667941 | |
dc.identifier.startpage | 7637 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/14935 | |
dc.identifier.volume | 27 | |
dc.identifier.wos | WOS:001076331800026 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Verduci Publisher | |
dc.relation.ispartof | European Review For Medical and Pharmacological Sciences | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Coronary artery disease | |
dc.subject | Myocardial infarction | |
dc.subject | Tumor necrosis factor-like weak inducer of apoptosis | |
dc.title | The usefulness of tumor necrosis factor-like weak inducer of apoptosis in patients with acute ST-elevation myocardial infarction | |
dc.type | Article |